TP53 and cancer: On the other hand, we independently discovered an anti-cancer compound, benzylamino-3-(1,2,3,4-tetrahydrocarbazol-9-yl)-propan-2-ol, termed GJC29 [9], shown in Figure 1(b), by the similar in silico screen using Autodock [10] based on the p53 structure [11].